GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (FRA:1RC) » Definitions » Shares Outstanding (Basic Average)

Creo Medical Group (FRA:1RC) Shares Outstanding (Basic Average) : 361.66 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Creo Medical Group Shares Outstanding (Basic Average)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Creo Medical Group's average basic shares outstanding for the quarter that ended in Jun. 2024 was 361.66 Mil.


Creo Medical Group Shares Outstanding (Basic Average) Historical Data

The historical data trend for Creo Medical Group's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group Shares Outstanding (Basic Average) Chart

Creo Medical Group Annual Data
Trend Feb14 Feb15 Feb16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only 125.84 161.43 170.38 187.90 313.00

Creo Medical Group Semi-Annual Data
Feb14 Feb15 Feb16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 181.29 194.50 266.48 359.53 361.66

Creo Medical Group Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Creo Medical Group  (FRA:1RC) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Creo Medical Group Shares Outstanding (Basic Average) Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's Shares Outstanding (Basic Average) provided by GuruFocus.com. Please click on the following links to see related term pages.


Creo Medical Group Business Description

Traded in Other Exchanges
Address
Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from Europe and the rest from the United Kingdom and the rest of the world.

Creo Medical Group Headlines

No Headlines